17 Predictive soluble biomarkers of immune response to checkpoint blockade in non-small cell lung cancer (NSCLC) patients

• Said Dermime,
• Maysaloun Merhi,
• Afsheen Raza,
• Shereena Hydrose,
• Shahab Uddin,
• Varghese Inchakalody,
• Mohammed Ussama Al Homsi,
• Reyad Mohsen,
• Aladdin Kanbour,
• Abdul Rehman Zar Gul,
• Anite Philip,
• Suma Vijayakumar

Affiliations

Said Dermime

Aff4 grid.415280.a0000000404023867King Fahad Specialist Hospital Dammam Saudi Arabia

Maysaloun Merhi

Medical Oncology, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Afsheen Raza

Medical Oncology, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Shereena Hydrose

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Shahab Uddin

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Varghese Inchakalody

Hamad Medical Corporation, Doha, Qatar

Mohammed Ussama Al Homsi

Hamad Medical Corporation, Doha, Qatar

Reyad Mohsen

Hamad Medical Corporation, DOHA, Qatar

Aladdin Kanbour

Hamad Medical Corporation, DOHA, Qatar

Abdul Rehman Zar Gul

Hamad Medical Corporation, DOHA, Qatar

Anite Philip

Hamad Medical Corporation, DOHA, Qatar

Suma Vijayakumar

Hamad Medical Corporation, DOHA, Qatar